associated with Food and Drug Administration (FDA)-mandated clinical trials of new drugs. But the relationship between the patent … system and other regulation of drugs is more complex than this simple formulation suggests. Drug regulation operates in …

new products. This paper addresses this gap in the context of new pharmaceuticals (15 new molecules in 34 countries) and … model, we find that differences in regulation substantially contribute to cross-country variation in sales. One of the … regulation such as restrictions of physician prescription budgets and the prohibition of direct-to-consumer advertising tend to …

a diminished role for direct price regulation. In framing a new drug-pricing policy, we believe Canada should pursue a … international burden-sharing system. In the area of patent legislation that relates to pharmaceuticals, the federal government …Over the past several years, the federal government has consulted widely in formulating new rules for the regulation of …

This working paper provides a statistical analysis of 74 patent families which cover subject matter relevant to ten … based on VaxPaL, a COVID-19 vaccines patent database developed by the Medicines Patent Pool (MPP). Through the detailed … examination of patent applicants, filing dates, and offices of first and subsequent filing, the paper identifies patterns and …

70 markets, the study finds that introduction of product patent for pharmaceuticals in the patent law has a positive …-income markets. Also, innovative pharmaceuticals are launched sooner than non-innovative ones, irrespective of the patent regime in …This paper examines access to new and innovative pharmaceuticals in a post-TRIPS era. The WTO’s TRIPS Agreement (TRIPS …

governments should bear the cost of the expected increased industry obsolescence determined by a temporary patent waiver; this … includes public patent-buy-outs and regulated public-private R&D partnerships. …

While the recent WTO agreement allowing developing countries to import life-saving drugs by bypassing patent laws is … beneficial, a majority of the drugs used to combat epidemics are off-patent or not patented in many developing countries …

international laws and policies impacting access to medicine is a dynamic process in which competing patent perspectives (as well as … their confluence) play an important role. Whereas patent-owning companies are usually considered to dominate conversations …

they conceptualise and consecutively propose to solve the problem of providing life-saving pharmaceuticals to the poor in …. However, there are important differences in detail: Pogge identifies the patent protection system as the crucial problem. He … opposes compulsory licensing, which annuls patent protection on a case by case basis, as a pseudo-solution. Instead, he …